LATANOPROST OPHTHALMIC SOLUTION
Google image searchProduct monograph
Active ingredient
latanoprost, 50 MCG/ML
DIN: 02489570
Dosage form(s): SOLUTION
Route(s) of administration: OPHTHALMIC
Schedule: Prescription
Company: HIKMA CANADA LIMITED
Date: 19-MAY-2022
ATC:
- S01 — OPHTHALMOLOGICALS (ATC, ATC/DDD, )
- S01E — ANTIGLAUCOMA PREPARATIONS AND MIOTICS (ATC, ATC/DDD)
- S01EE — Prostaglandin analogues (ATC, ATC/DDD)
- S01EE01 — LATANOPROST (ATC/DDD)
Reference brand drug: Xalatan
